{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:37:29Z","timestamp":1789771049780,"version":"4.0.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department for the Economy, Northern Ireand (URL: https:\/\/www.nidirect.gov.uk\/articles\/department-economy-studentships)","award":["PhD Studentship"],"award-info":[{"award-number":["PhD Studentship"]}]},{"name":"Invest Northern Ireland, Proof of Concept Funding (URL: https:\/\/www.investni.com\/support-for-business\/proof-of-concept.html)","award":["PoC518"],"award-info":[{"award-number":["PoC518"]}]},{"name":"Invest Northern Ireland, Proof of Concept Funding (URL: https:\/\/www.investni.com\/support-for-business\/proof-of-concept.html)","award":["PoC518"],"award-info":[{"award-number":["PoC518"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202350","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T18:40:21Z","timestamp":1535568021000},"page":"e0202350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-4239","authenticated-orcid":true,"given":"Finbarr P. M.","family":"O\u2019Harte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivel","family":"Parthsarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"issue":"Suppl. 1","key":"ref1","first-page":"S13","article-title":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u2013 2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function","volume":"42","author":"SE Kahn","year":"1993","journal-title":"Diabetes"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","article-title":"Loss of incretin effect is a specific, important, and early charactersitic of type 2 diabetes","volume":"34","author":"JJ Holst","year":"2011","journal-title":"Diabetes Care"},{"key":"ref4","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","author":"NH Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"RA DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/pubmed\/24.3.170","article-title":"Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population","volume":"24","author":"L Hayes","year":"2002","journal-title":"J Public Health Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"e32619","DOI":"10.1371\/journal.pone.0032619","article-title":"Socio-Economic Position and Type 2 Diabetes Risk Factors: Patterns in UK Children of SouthAsian, Black African-Caribbean and White European Origin","volume":"7","author":"C Thomas","year":"2012","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies","volume":"371","author":"T Mazzone","year":"2008","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"DS Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"ref10","first-page":"2123","article-title":"Evaluation and prevention of diabetic neuropathy","volume":"71","author":"AM Aring","year":"2005","journal-title":"Am Fam Physician"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"JL Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.3390\/ijms140510497","article-title":"Obesity-associated oxidative stress: strategies finalized to improve redox state","volume":"14","author":"I Savini","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jmf.2012.2249","article-title":"Randomized double-blind placebo-controlled trial of powdered Brassica rapa ethanol extract on alteration of body composition and plasma lipid and adipocytokine profiles in overweight subjects","volume":"16","author":"SM Jeon","year":"2013","journal-title":"J Medicinal Food"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"R Loomba","year":"2013","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14779072.2015.1054810","article-title":"Liraglutide for Type 2 diabetes and obesity: a 2015 update","volume":"13","author":"EW Iepsen","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clinthera.2017.03.013","article-title":"Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists","volume":"39","author":"Q Ji","year":"2017","journal-title":"Clin Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"MA Nauck","year":"2011","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cpt.144","article-title":"The current drug treatment landscape for diabetes and perspectives for the future","volume":"98","author":"CJ Bailey","year":"2015","journal-title":"Clin Pharmacol Therapeutics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4239\/wjd.v6.i15.1285","article-title":"New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders","volume":"6","author":"N Irwin","year":"2015","journal-title":"World J Diabetes"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1210\/en.2004-1427","article-title":"Apelin, a Newly Identified Adipokine Up-Regu- lated by Insulin and Obesity","volume":"146","author":"J Boucher","year":"2005","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"BF O'Dowd","year":"1993","journal-title":"Gene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"23","author":"Y Kawamata","year":"2001","journal-title":"Biochimica Biophysica Acta"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"K Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JOE-13-0227","article-title":"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis","volume":"219","author":"AM O'Carroll","year":"2013","journal-title":"J Endocrinol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2016.07.012","article-title":"Apelin\/APJ system as a therapeutic target in diabetes and its complications","volume":"119","author":"H Hu","year":"2016","journal-title":"Mol Genet Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/gutjnl-2015-310230","article-title":"Apelin targets gut contraction to control glucose metabolism via the brain","volume":"66","author":"A Fournel","year":"2017","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1096\/fj.201600784R","article-title":"Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects","volume":"31","author":"R Gerbier","year":"2017","journal-title":"FASEB J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2017.10.002","article-title":"Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties","volume":"146","author":"FPM O'Harte","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1021\/jm070861j","article-title":"Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness","volume":"50","author":"K Madsen","year":"2007","journal-title":"J Med Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.peptides.2017.12.004","article-title":"Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions","volume":"100","author":"FPM O'Harte","year":"2018","journal-title":"Peptides"},{"key":"ref31","first-page":"R658","article-title":"Dietary obesity in the mouse: interaction of strain with diet composition","volume":"268","author":"D.B. West","year":"1995","journal-title":"Am. J. Physiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0026-0495(98)90304-3","article-title":"Differential effects of fat and sucrose on body composition in A\/J and C57BL\/6 mice","volume":"47","author":"B.L. Black","year":"1998","journal-title":"Metabolism"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/oby.2007.608","article-title":"High-fat diets: modeling the metabolic disorders of human obesity in rodents","volume":"15","author":"R Buettner","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/dom.13068","article-title":"Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice","volume":"20","author":"V Parthsarathy","year":"2018","journal-title":"Diabetes Obes Metabolism"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/dom.12360","article-title":"Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic mice","volume":"16","author":"FPM O'Harte","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"PR Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00125-016-4186-y","article-title":"An enzymatically stable GIP\/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice","volume":"60","author":"A Hasib","year":"2017","journal-title":"Diabetologia"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-17-0263","article-title":"Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice","volume":"234","author":"P Millar","year":"2017","journal-title":"J Endocrinol"},{"key":"ref39","first-page":"207","article-title":"The role of adipose tissue and adipokines in obesity-related inflammatory diseases","volume":"80","author":"CR Balistreri","year":"2010","journal-title":"Mediators of Inflamm"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ijo.2014.122","article-title":"Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin","volume":"39","author":"C Alfarano","year":"2015","journal-title":"Int J Obes. (Lond.)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fphys.2015.00115","article-title":"Apelin and energy metabolism","volume":"6","author":"C Bertrand","year":"2015","journal-title":"Front Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/HYPERTENSIONAHA.116.08916","article-title":"Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity","volume":"69","author":"F Schinzari","year":"2017","journal-title":"Hypertension"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"MJ Kleinz","year":"2005","journal-title":"Regul Pept"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/ajpendo.00598.2009","article-title":"Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans","volume":"298","author":"C Dray","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1530\/EJE-08-0039","article-title":"Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ","volume":"158","author":"I Castan-Laurell","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2008.10.003","article-title":"Apelin stimulates glucose utilization in normal and obese insulin-resistant mice","volume":"28","author":"C Dray","year":"2008","journal-title":"Cell Metabolism"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11010-011-0799-0","article-title":"Apelin stimulates glucose uptake through the PI3K\/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes","volume":"353","author":"S Zhu","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2826.2007.01617.x","article-title":"Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL\/6 mice","volume":"20","author":"A Valle","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/en.2006-1270","article-title":"Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice","volume":"148","author":"K Higuchi","year":"2007","journal-title":"Endocrinology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/ajpendo.00385.2009","article-title":"Apelin is necessary for the maintenance of insulin sensitivity","volume":"298","author":"P Yue","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"18","key":"ref51","first-page":"30093","article-title":"Vascular effects of apelin: Mechanisms and therapeutic potential","author":"A Mughal","year":"2018"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model","volume":"61","author":"B Gier","year":"2012","journal-title":"Diabetes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:45:03Z","timestamp":1720550703000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202350"}},"subtitle":[],"editor":[{"given":"Christian","family":"Holscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]}}}